News Channels

30 Sep 2017 FDA approves new treatment for certain advanced or metastatic breast cancers
30 Sep 2017 INSYS Therapeutics Files New Drug Application (NDA) for Buprenorphine Sublingual Spray with FDA
30 Sep 2017 CHMP endorses Tresiba® label update in the EU - new label reflects significant reduction in the risk of severe hypoglycaemia
30 Sep 2017 Novo Nordisk's new fast-acting mealtime insulin Fiasp® approved in the US
30 Sep 2017 Zogenix Announces Positive Top-line Results from Pivotal Phase 3 Clinical Trial of ZX008 in Dravet Syndrome
30 Sep 2017 Merck Discontinues MK-3682B and MK-3682C Development Programs
29 Sep 2017 Nohla Therapeutics Awarded $6.9 Million Grant from the California Institute of Regenerative Medicine to Further Develop NLA101 Cell Therapy for the Treatment of Patients with Acute Myeloid Leukemia
29 Sep 2017 Prothena Reports Results from Phase 1b Multiple Ascending Dose Study of PRX003 in Patients with Psoriasis
29 Sep 2017 bluebird bio Announces First Patient Treated with Second Anti-BCMA CAR T bb21217 in CRB-402 Phase 1 Study in Patients with Relapsed/Refractory Multiple Myeloma
29 Sep 2017 FDA Grants Priority Review for Genentech’s Perjeta® (Pertuzumab) for Adjuvant Treatment of HER2-Positive Early Breast Cancer
29 Sep 2017 Alcobra Ltd. and Arcturus Therapeutics, Inc. Agree to Merge
28 Sep 2017 Genelux Initiates Phase 2 Clinical Trial of GL-ONC1 in Recurrent Ovarian Cancer
28 Sep 2017 Eidos Therapeutics Initiates First Clinical Study for AG10 Targeting Transthyretin Amyloidosis, Appoints Camille Landis as Chief Business Officer
28 Sep 2017 Asterias Receives Regulatory Clearance to Initiate Clinical Study of AST-VAC2 in Subjects with Early and Late Stage Non-Small Cell Lung Cancer
28 Sep 2017 Ascendis Pharma A/S Announces Dosing of Subjects in Phase 1 Trial of TransCon PTH
28 Sep 2017 Poseida Therapeutics Opens Enrollment in a Phase 1 Study of BCMA-Specific CAR-T Stem Cell Memory Therapy for Patients with Multiple Myeloma
28 Sep 2017 Fibrocell Reports Interim Results of Phase 1/2 Clinical Trial of FCX-007 Gene Therapy for Recessive Dystrophic Epidermolysis Bullosa
28 Sep 2017 AzurRx BioPharma and Mayoly-Spindler Announce Positive MS1819-SD Phase II Data in Exocrine Pancreatic Insufficiency (EPI)
28 Sep 2017 Protagenic’s Neuropeptide Shows Strong Efficacy in Treating Depression and Anxiety of Established Rodent Models
28 Sep 2017 Thermalin Announces: Collaboration with Sanofi to Develop Next Generation Insulin Therapies

La Merie Biologics

FREE Weekly News Bulletin

2016 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Top